Inventor · disambiguated record
István Puskás
Also filed as: PUSKAS ISTVAN · PUSKAS ISTVÁN · PUSKÁS ISTVÁN
7 granted patents·8 pending applications·33 citations·filing 1989–2024
78Inventor score
Files withCYCLOLAB CYCLODEXTRIN RES AND DEVELOPMENT LABORATORY LTD7ADAMA MAKHTESHIM LTD2INQPHARM SDN BHD2CHONG PEE WIN1FOEVAROSI TANACS GYOGYSZERTARI1
Top patents by PatentIndex Score
15 records- 0181US12127559B2Use of cyclodextrins as agrochemical delivery systemADAMA MAKHTESHIM LTD·Filed 2019·Granted Oct 29, 2024·1 cites·24 claims
- 0274US2025057161A1Use of cyclodextrins as agrochemical delivery systemADAMA MAKHTESHIM LTD·Filed 2024·Application pending·0 cites
- 0373US9480755B2Pharmaceutical composition comprising dapagliflozin and cyclodextrinPUSKAS ISTVÁN·Filed 2012·Granted Nov 1, 2016·2 cites·18 claims
- 0468USRE50534ECyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseasesCYCLOLAB CYCLODEXTRIN RES AND DEVELOPMENT LABORATORY LTD·Filed 2023·Granted Aug 19, 2025·0 cites·4 claims
- 0568US5043153ACompositions for the prevention and medical treatment of parodonthopathyFOEVAROSI TANACS GYOGYSZERTARI·Filed 1989·Granted Aug 27, 1991·30 cites·5 claims
- 0664US11446325B2Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseasesCYCLOLAB CYCLODEXTRIN RES AND DEVELOPMENT LABORATORY LTD·Filed 2020·Granted Sep 20, 2022·0 cites·4 claims
- 0757US2023346825A1Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseasesCYCLOLAB CYCLODEXTRIN RES AND DEVELOPMENT LABORATORY LTD·Filed 2021·Application pending·0 cites
- 0853US11649299B2Purification of sulfobutylated cyclodextrins with specific ion exchange resinsCYCLOLAB CYCLODEXTRIN RES AND DEVELOPMENT LABORATORY LTD·Filed 2021·Granted May 16, 2023·0 cites·8 claims
- 0951US2024325419A1Pharmaceutical composition for restoring physiological processes and cells of organismKURKAYEV ABDULA·Filed 2022·Application pending·0 cites
- 1049US2022282001A1Stabilization of proteins with cyclodextrinsCYCLOLAB CYCLODEXTRIN RES AND DEVELOPMENT LABORATORY LTD·Filed 2021·Application pending·0 cites
- 1147US2022152087A1Cyclodextrin derivatives reducing flavivirus ns1-induced endothelial hyperpermeability and vascular leakCYCLOLAB CYCLODEXTRIN RES AND DEVELOPMENT LABORATORY LTD·Filed 2020·Application pending·0 cites
- 1247US2021145816A1Pharmaceutical formulation of lonafarnib with a sulfobutylether beta-cyclodextrinCYCLOLAB CYCLODEXTRIN RES AND DEVELOPMENT LABORATORY LTD·Filed 2019·Application pending·0 cites
- 1342US2018325941A1Composition for reducing absorption of dietary fatINQPHARM SDN BHD·Filed 2018·Application pending·0 cites
- 1439US9107441B2Composition for reducing absorption of dietary fatCHONG PEE WIN·Filed 2011·Granted Aug 18, 2015·0 cites·16 claims
- 1534US2016051574A1Composition for reducing absorption of dietary fatINQPHARM SDN BHD·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →